Pfizer, the pharmaceutical giant, is now a household name, thanks to developing one of the leading vaccines against COVID-19. Now, an Israeli startup will help the New York-based firm produce the next generation of drugs more efficiently and effectively — whether that’s a booster shot against the novel coronavirus or an entirely different class of drugs.

Read more here.